Alpine Immune Sciences • ALPN
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company dedicated to discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Mitchell H. Gold,M.D.$4.2B
Market Cap • 17/04/20242014
(há 10 anos)
2015
(9 years ago)
NASDAQ
Listagem
Seattle
Sede • Washington126
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ALPNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.